Trial Profile
A Phase 2a Randomized, Double-blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Effects Of PF-05175157 On Moderate To Severe Acne Vulgaris In Adult Subjects
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2014
Price :
$35
*
At a glance
- Drugs PF 5175157 (Primary)
- Indications Acne vulgaris
- Focus Adverse reactions
- Sponsors Pfizer
- 12 May 2014 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 03 Apr 2014 New trial record